Skip to main content

Illumina Stock Up 16.7 Percent After Robert W. Baird Upgrade

NEW YORK, March 30 (GenomeWeb News) - Shares in Illumina were up 16.76 percent, or $1.17, at $8.15 in mid-afternoon trading after Robert W. Baird upgraded the company's stock to "outperform" from "neutral."

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.